Besides PARP-BRCA1/2 pairs, DDR sensor kinases ATM, ATR and DNA-PK recently gained attention as synthetic lethal partners [38] in different tumour types, as demonstrated by the increasing number of their inhibitors in clinical trials [2]. The gene discussed is BRCA1; the disease is neoplasm.